Amber Enterprises reported a strong performance in its third-quarter earnings, with a net profit of ₹37 crore, reversing a loss of ₹0.5 crore year-over-year. The company's revenue surged 64.8% to ₹2,133.3 crore, exceeding the CNBC-TV18 poll estimate of ₹1,722 crore. EBITDA also improved, reaching ₹158.7 crore compared to ₹78.5 crore in the previous year. Following the announcement, the stock surged by 9.90%. In contrast, Mankind Pharma's third-quarter results showed a decline in net profit by 16.2% to ₹380.2 crore, down from ₹453.8 crore year-over-year. However, the company reported a revenue increase of 24% to ₹3,230 crore, surpassing last year's ₹2,607 crore. Mankind Pharma's EBITDA rose 36.8% to ₹830 crore, with a margin improvement to 25.7% from 23.3% year-over-year. The mixed results for Mankind Pharma were attributed to rising expenses.